Fatal Fulminant Hepatitis E in a Diabetic Patient on Metformin
- PMID: 36292073
- PMCID: PMC9600022
- DOI: 10.3390/diagnostics12102385
Fatal Fulminant Hepatitis E in a Diabetic Patient on Metformin
Abstract
Hepatitis E is mostly autochthonous in Western developed countries, eating pig-derived products being the most frequently documented source. Hepatitis E virus (HEV) infection is usually asymptomatic or self-limiting, but it can cause acute liver failure. HEV serological testing was performed using EUROIMMUN immunoenzymatic assays. HEV RNA in the serum was determined using an in-house real-time reverse transcriptase PCR procedure. The HEV genotype was determined through phylogenetic analysis after Sanger sequencing was performed using an in-house procedure. The case patient, an immunocompetent patient in his 60s with type 2 diabetes and no documented chronic liver disease, was hospitalized in February 2021 in an intensive care unit due to an initially unexplained coma. He presented metformin overdose and fulminant hepatitis E (HEV RNA in the serum was 4,140,000 copies/mL) that evolved toward death. The HEV genotype was 3f. We identified eight previous hepatitis E in diabetic patients, but with no metformin excessive plasma concentration, in the literature. Three patients were liver transplant recipients and three died. HEV infection can be severe and life-threatening in diabetic patients, which warrants HEV testing in this special population in the case of an altered general condition and/or liver cytolysis.
Keywords: death; diabetes; fulminant hepatitis; hepatitis E; metformin.
Conflict of interest statement
The authors have no conflict of interest to declare.
Figures

Similar articles
-
Liver transplantation for acute liver failure related to autochthonous genotype 3 hepatitis E virus infection.Clin Res Hepatol Gastroenterol. 2014 Feb;38(1):24-31. doi: 10.1016/j.clinre.2013.05.013. Epub 2014 Jan 23. Clin Res Hepatol Gastroenterol. 2014. PMID: 24462173
-
Hepatitis E virus in patients with acute severe liver injury.World J Hepatol. 2014 Jun 27;6(6):426-34. doi: 10.4254/wjh.v6.i6.426. World J Hepatol. 2014. PMID: 25018853 Free PMC article.
-
Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.Liver Transpl. 2010 Jan;16(1):74-82. doi: 10.1002/lt.21958. Liver Transpl. 2010. PMID: 19866448
-
Hepatitis E: An emerging infection in high income countries.J Clin Virol. 2014 Feb;59(2):81-8. doi: 10.1016/j.jcv.2013.11.013. Epub 2013 Dec 11. J Clin Virol. 2014. PMID: 24388207 Review.
-
Parsonage-Turner syndrome associated with hepatitis E infection in immunocompetent patients.Virus Res. 2020 Dec;290:198165. doi: 10.1016/j.virusres.2020.198165. Epub 2020 Sep 29. Virus Res. 2020. PMID: 33007343 Review.
Cited by
-
Cholestasis in hepatitis E virus infection.World J Hepatol. 2025 Apr 27;17(4):99899. doi: 10.4254/wjh.v17.i4.99899. World J Hepatol. 2025. PMID: 40308815 Free PMC article.
References
-
- Smith D.B., Izopet J., Nicot F., Simmonds P., Jameel S., Meng X.-J., Norder H., Okamoto H., van der Poel W.H.M., Reuter G., et al. Update: Proposed reference sequences for subtypes of hepatitis E virus (species Orthohepevirus A) J. Gen. Virol. 2020;101:692–698. doi: 10.1099/jgv.0.001435. - DOI - PMC - PubMed
-
- Aherfi S., Borentain P., Raissouni F., Le Goffic A., Guisset M., Renou C., Grimaud J.-C., Hardwigsen J., Garcia S., Botta-Fridlund D., et al. Liver transplantation for acute liver failure related to autochthonous genotype 3 hepatitis E virus infection. Clin. Res. Hepatol. Gastroenterol. 2014;38:24–31. doi: 10.1016/j.clinre.2013.05.013. - DOI - PubMed
-
- Van Cauteren D., Le Strat Y., Sommen C., Bruyand M., Tourdjman M., Da Silva N.J., Couturier E., Fournet N., de Valk H., Desenclos J.-C. Estimated Annual Numbers of Foodborne Pathogen-Associated Illnesses, Hospitalizations, and Deaths, France, 2008–2013. Emerg. Infect. Dis. 2017;23:1486–1492. doi: 10.3201/eid2309.170081. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources